TABLE 2.
Comparison of activities of selected HR2 peptides in plaque-forming and RT infectivity assays
| Peptide | Plaque-forming assaya
|
RT infectivity assaya
|
||
|---|---|---|---|---|
| EC50 (μM) | EC90 (μM) | EC50 (μM) | EC90 (μM) | |
| T1569 | 0.026 | 0.117 | 0.055 | 0.106 |
| T1577 | 0.050 | 0.162 | 0.098 | 0.177 |
| T1578 | 0.020 | 0.090 | 0.053 | 0.157 |
| T1588 | 0.030 | 0.125 | 0.168 | 0.423 |
EC50s and EC90s for each peptide were determined using the Karber method.